European pharma industry investment outlook
After lobbying the EU, European pharma has begun to respond to potential tariffs by increasing US investment.
The complicated hunt for water on the Moon
NASA’s Artemis Project has set the goal of establishing a permanent crewed base on the Moon by the end of the decade. But one of the most significant obstacles to humans surviving on the Moon is the availability of clean water. Astronauts will need a reliable supply for drinking and growing food.
Business digest
The latest business digest for C&I Issue 5 2025 with all the latest mergers and acquisitions in the chemical industry.
Academic journal highlights: Applied chemistry
Expert scientists summarise some of their selected research papers from recent journal issues. Read the highlights from Nigel P Freestone, University of Northampton, UK in Issue 5 2025 of C&I.
US Food and Drug Administration attacked as under industry’s spell
The US Food & Drug Administration (FDA) found itself under attack by the Department of Health & Human Services Secretary Robert F Kennedy at a welcome event for the newly-instated FDA Commissioner Marty Makary.
US specialty and fine chemicals gain ground
US specialty and fine chemicals volumes rose 0.6% up to reach 3.53m t in March 2025, up 1.6% y/y, compared with March 2024, according to figures from US consultant, Swift Economics.
Could pharma tariffs be next?
While the Trump Administration has vacillated over the scope and size of trade tariffs it plans to impose, there remains a threat that tariffs will also be applied to pharmaceuticals at some point.
Transformative trends in biotech
The biotechnology industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing and real-time analytics reshaping drug discovery, personalised medicine and healthcare delivery.